Knowledge graph · Trial
An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States
COMPLETED
- Identifier
- CI-TRIAL-00075835
- Entity page
- /trial/NCT06204302 ↗
- Edges
- 3
- Neighbours
- 3 drugs
- Drawn
- 3 of 3 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States intervention of …INTERVENTION_OFderived3 of 3 | ||||||||
| ← intervention of | Apalutamidesmall molecule registry intervention “Apalutamide” (DRUG) mapped ALIAS | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| ← intervention of | Darolutamidesmall molecule registry intervention “Darolutamide (Nubeqa, BAY1841788)” (DRUG) mapped ALIAS | — | — | |||||